NCT00529269View on ClinicalTrials.gov

Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

June 30, 2007

Conditions
Renal Transplant
Interventions
DRUG

Enteric-Coated Mycophenolate Sodium (EC-MPS)

Trial Locations (2)

Unknown

Novartis Investigative Site, Busan

Novartis Investigative Site, Seoul

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY